Experimental Therapy of Breast Cancer with Anti-breast Epithelial Radioimmunoconjugates

  • Roberto L. Ceriani
  • Edward W. Blank


Therapy of breast cancer with monoclonal antibodies (MoAbs) conjugated or unconjugated faces serious challenges not only for researchers to obtain MoAbs adequate to bring the desired conjugate to the tumors and spare other organs, but also to create MoAbs that could act in an unconjugated form. Of the latter type, those that will participate in antibody dependent cell mediated and complement dependent cytotoxicity are desired.


Nude Mouse Human Breast Carcinoma Human Breast Tumor Complement Dependent Cytotoxicity Human Breast Epithelial Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M. Sasaki, J.A. Peterson, and R.L. Ceriani. Monoclonal antibodies against breast epithelial cell surface antigens in breast cancer therapy. Hybridoma, 2:120 (1983).Google Scholar
  2. 2.
    D.J. Hnatowich, F. Virri, and P.W. Doherty. DTPA-coupled antibodies labelled with yttrium-90. J. Nucl. Med. 26:503 (1985).PubMedGoogle Scholar
  3. 3.
    G.C. Buehring. Effect of hormones and chemicals on expression of milk fat globule antigens by breast cell line MCF-7. In Vitro, 22:50A (1986).Google Scholar
  4. 4.
    P.M. Capone. L.D. Papsidero. G.A. Croghan. and T.M. Chu. Experimental tumoricidal effects of monoclonal antibody against solid tumors. Proc. Natl. Acad. Sci. USA. 80:7328 (1983).PubMedCrossRefGoogle Scholar
  5. 5.
    P.M. Capone. L.D. Papsidero. and T.M. Chu. Relationship between antigen density and immunotherapeutic response elicited by monoclonal antibodies against solid tumors. J. Natl. Cancer. Inst., 72:673 (1984).PubMedGoogle Scholar
  6. 6.
    R.L. Ceriani. E.W. Blank, and J.A. Peterson. Experimental immunotherapy of human breast carcinomas implanted in nude mice with a mixture of monoclonal antibodies against human milk fat globule components. Cancer Res. 47:532 (1987).PubMedGoogle Scholar
  7. 7.
    J.A. Peterson. R.L. Ceriani. E.W. Blank, and L. Osvaldo. Comparison of rates of phenotypic variability in surface antigen expression in normal and cancerous human breast epithelial cells. Cancer Res., 43:4291 (1983).PubMedGoogle Scholar
  8. 8.
    R.L. Ceriani, J.A. Peterson, and E.W. Blank. Variability in surface antigen expression of human breast epithelial cells cultured from normal breast, normal tissue peripheral to breast carcinomas, and breast carcinomas. Cancer Res., 44:3033 (1984).PubMedGoogle Scholar
  9. 9.
    M. Monaco, J. Mack, M. Dugan, and R.L. Ceriani. Synthesis of monoclonal antibody-toxin conjugates which specifically interact with MCF-7 breast carcinoma cells. Ann. N.Y. Acad. Sci., 464:389 (1986).PubMedCrossRefGoogle Scholar
  10. 10.
    K.M. Hwang, E.W. Blank, and R.L. Ceriani. Experimental immunotherapy of human breast tumors with conjugated and unconjugated monoclonal antibodies. 8th Annual San Antonio Breast Cancer Symp., Nov. (1985).Google Scholar
  11. 11.
    F.C. Greenwood, W.M. Hunter, and J.I. Glover. The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochem. J., 89:114 (1963).PubMedGoogle Scholar
  12. 12.
    M. Sasaki, J.A. Peterson, W. Wara, and R.L. Ceriani. Human mammary antigens (HME-Ags) in the circulation of nude mice implanted with breast and non-breast tumors. Cancer, 48:2214 (1981).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Roberto L. Ceriani
    • 1
  • Edward W. Blank
    • 1
  1. 1.John Muir Cancer & Aging Research InstituteWalnut CreekUSA

Personalised recommendations